This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brigante, G.
Right arrow Articles by Stefani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brigante, G.
Right arrow Articles by Stefani, S.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2008, p. 3826-3828, Vol. 46, No. 11
0095-1137/08/$08.00+0     doi:10.1128/JCM.00877-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Identification of Coagulase-Negative Staphylococci by Using the BD Phoenix System in the Low-Inoculum Mode{triangledown}

Gioconda Brigante,2 Maria Grazia Menozzi,3 Beatrice Pini,2 Rosaria Porta,1 Pietro Somenzi,3 Agata Sciacca,4 Teresa Spanu,1 and Stefania Stefani5*

Institute of Microbiology, Università Cattolica del Sacro Cuore, Rome,1 Laboratory of Medical Microbiology, University of Insubria and Ospedale di Circolo, Varese,2 Department of Pathology and Laboratory Medicine, Section of Microbiology, University of Parma, Parma,3 Laboratory of Microbiology, Azienda Policlinico, University of Catania, Catania,4 Department of Microbiological and Gynecological Sciences, Section of Microbiology, University of Catania, Catania, Italy5

Received 7 May 2008/ Returned for modification 27 July 2008/ Accepted 2 September 2008


arrow
ABSTRACT
 
The new "low-inoculum" mode of the Phoenix system was evaluated to identify clinical coagulase-negative staphylococci. API ID32 Staph panels were used as comparators, and discrepancies were resolved by 16S rRNA and tuf gene analysis. The system correctly identified 90.5% of isolates, with a mean time of 10.2 h. Accuracy was satisfactory for Staphylococcus epidermidis, S. saprophyticus, and S. haemolyticus.


arrow
TEXT
 
Coagulase-negative staphylococci (CoNS) have long been considered members of the saprophytic flora and are rarely pathogens. Over the last 2 decades, CoNS have emerged as significant pathogens, especially among compromised hosts and patients undergoing complex medical procedures. In many instances, CoNS are involved in nosocomial infections related to indwelling medical devices and prostheses (6, 16).

It should be noted that in addition to the most frequent CoNS species isolated from humans (i.e., Staphylococcus epidermidis, Staphylococcus haemolyticus, and Staphylococcus saprophyticus), at least nine additional CoNS species have been isolated from clinical specimens and from food (11, 17). Thus, comprehensive and accurate identification (ID) of Staphylococcus species is of great importance, together with drug susceptibility testing. Several ID methods for gram-positive, catalase-positive cocci are commercially available, including manual, semiautomated, and automated systems. Among these, the API ID32 Staph system (bioMérieux, Marcy l'Étoile, France) is highly reputed for its accuracy (2, 4, 7, 8, 14).

Becton Dickinson (Sparks, MD) has developed recent software and algorithms for identifying clinically relevant pathogens for its Phoenix (PHX) automated bacterial ID system, using a low-inoculum mode (low mode) that uses a 0.25 instead of the standard 0.5 McFarland inoculum size. The new low mode was developed to increase ID accuracy by using already available Becton Dickinson panels. Results of ID plus drug susceptibility testing are produced within 18 h.

Four Italian microbiology laboratories (in Catania, Parma, Rome, and Varese) performed a multicenter study designed to assess the ability of the PHX system to identify clinical CoNS isolates by use of the new low mode. Isolates consecutively collected during the first 6 months of 2006 were investigated; isolates were obtained from blood-, catheter-, and wound-associated infections. The following 10 CoNS reference strains of different species were obtained from the American Type Culture Collection (ATCC) and used for proficiency tests: S. aureus, S. epidermidis, S. cohnii subsp. urealyticum, S. haemolyticus, S. hominis, S. saprophyticus, S. sciuri, S. schleiferi subsp. coagulans, S. simulans, and S. xylosus.

Overall, 200 isolates were biochemically identified using the new PHX low mode. The API system was used as a comparator. In the case of disagreement between the two phenotypic methods, both assays were repeated. When discrepancies persisted, ID was first confirmed by direct DNA sequencing of the 16S rRNA gene (15). If no reliable ID was produced by this method, the tuf housekeeping gene was sequenced (8). With regard to staphylococcal species, the tuf gene is considered more discriminatory than the conserved rrn genes (15).

Twelve different species were identified among the investigated isolates. Concordant IDs between the API and PHX systems were obtained in 88.5% of cases (data not shown). Discordant IDs were obtained for 23/200 isolates (11.5%). Highly concordant results were obtained for S. epidermidis and S. haemolyticus isolates (96% and 93%, respectively). Seven isolates were not identified by the PHX system. Isolates producing discordant results were identified by molecular methods. Table 1 shows the resolution of discrepancies by molecular methods. Sequencing of the 16S rRNA gene succeeded in identifying 11/23 strains of three different species (S. epidermidis, S. hominis, and S. lugdunensis). The IDs of the remaining 12 strains were obtained by tuf gene sequencing (S. epidermidis, S. capitis, S. haemolyticus, and S. warneri). Compared with molecular ID results, the API system correctly identified 16/23 discordant isolates (for S. epidermidis, n = 4; for S. capitis, n = 2; for S. warneri, n = 2; for S. hominis, n = 7; and for S. lugdunensis, n = 1). The PHX system correctly identified 4/23 strains (for S. haemolyticus, n = 2; for S. warneri, n = 1; and for S. hominis, n = 1).


View this table:
[in this window]
[in a new window]

 
TABLE 1. Resolution by molecular assays of discordant ID results obtained for CoNS isolates (n = 23)a

As shown in Table 2, after discrepancy resolution by molecular tests, the PHX system gave an overall correct ID in 90.5% of cases. An incorrect ID or no ID was obtained in 6% and 3.5% of isolates, respectively. The API system correctly identified 96.5% of isolates. Incorrect ID was obtained in 3.5% of cases. The performance of the PHX system was particularly good with regard to the following species: S. epidermidis (96%), S. haemolyticus (97.5%), and S. saprophyticus (100%). Low ID accuracy was obtained with regard to S. hominis isolates (69.6%).


View this table:
[in this window]
[in a new window]

 
TABLE 2. Identification of CoNS isolates by use of API ID32 Staph panels and the PHX low-mode systema

The increasing isolation rate of CoNS in modern clinical medicine makes these agents interesting emerging pathogens. Thus, accurate and rapid CoNS ID is clinically relevant for patient management and for the prompt detection of nosocomial outbreaks (10). In addition, it should be noted that for staphylococci, species ID is essential for interpreting antimicrobial susceptibility tests (3).

A few studies have been published on the ability of the PHX system to identify CoNS. In a two-center study, Fahr and colleagues (5) tested the PHX performance with regard to 275 staphylococcal isolates that included several S. aureus strains. Good ID concordance with the comparators (Vitek and API ID32 Staph systems) was obtained for 153/161 CoNS isolates (95.1%). In contrast to the conclusions of Fahr (5), two recent papers (9, 14) have reported on the poor performance of the PHX system with regard to CoNS for the 0.5 McFarland inoculum mode. In both studies, discordant IDs were solved using molecular methods. The data underlined the difficulties encountered in identifying S. epidermidis and S. hominis isolates.

The present ID results, obtained using the recently developed PHX low mode, show improved overall performances. After resolution of discrepancies, the system gave a correct ID for 90.5% of isolates. The API panels provided a correct ID in 96.5% of cases. Particularly good performances of the PHX system were observed with regard to S. epidermidis, S. saprophyticus, and S. haemolyticus. In contrast, difficulties were encountered in identifying S. hominis isolates (69.6%). This problem may be attributed to missing ID keys in the database for one of the two varieties of this species (S. hominis subsp. novobiosepticus), a recently recognized pathogen (12). As a final note, the study also revealed that the PHX low mode produced ID and drug susceptibility results within a time frame satisfactory for prompt patient management. With regard to CoNS, the measured mean time to results was 10.2 h (range, 2.2 to 18.5 h; standard deviation, 4.7 h).

With regard to genotypic methods, several targets have been exploited for identifying species belonging to the Staphylococcus genus (7, 13, 15). Because of the large amount of rrs sequence data available in public databases, it is not surprising that the 16S rRNA gene has been the favorite choice. rrs gene sequences are highly significant at the genus level, but their role in staphylococcal species ID has been questioned (1, 8). Thus, tuf gene sequences have emerged as a reliable species identifier (7, 9, 15). The present results confirm that incorrect ID of 12/23 isolates was obtained through 16S rRNA sequencing. In these cases, sequences of the tuf gene were discriminatory at the species level.

In conclusion, the PHX low mode correctly identified 90.5% of CoNS isolates, including those most frequently encountered in the clinical setting (S. epidermidis, S. haemolyticus, and S. saprophyticus). Poor performances were produced with regard to S. hominis. In the clinical setting, new technology appears to be closing the gap between bacterial isolation and accurate ID plus drug susceptibility testing of hard-to-define pathogens, such as the many staphylococcal species. We look to the day when automatic, reliable, and rapid systems will be commonplace in medical microbiology laboratories.


arrow
ACKNOWLEDGMENTS
 
We acknowledge Maria Santagati, Marina Scillato, and Antony Bridgewood for technical assistance. We also acknowledge the invaluable assistance of Gioia Babini and Enrico Montrucchio (BD Diagnostic Systems). We are also indebted to Giuseppe Dettori (Parma, Italy), Giovanni Fadda (Rome, Italy), Francesco Luzzaro (Varese, Italy), Giuseppe Nicoletti (Catania, Italy), and Antonio Toniolo (Varese, Italy) for their constructive advice and manuscript revision.

This work was sponsored by Becton Dickinson and Company through its Diagnostic System Division (Milan, Italy).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology, University of Catania, Via Androne 81, 95124 Catania, Italy. Phone: 39 095-2504714. Fax: 39 095-2504733. E-mail: stefanis{at}unict.it Back

{triangledown} Published ahead of print on 10 September 2008. Back


arrow
REFERENCES
 
    1
  1. Becker, K., D. Harmsen, A. Mellmann, C. Meier, P. Schumann, G. Peters, and C. von Eiff. 2004. Development and evaluation of a quality-controlled ribosomal sequence database for 16S ribosomal DNA-based identification of Staphylococcus species. J. Clin. Microbiol. 42:4988-4995.[Abstract/Free Full Text]
  2. 2
  3. Carroll, K. C., A. P. Borek, C. Burger, B. Glanz, H. Bhally, S. Henciak, and D. C. Flayhart. 2006. Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci. J. Clin. Microbiol. 44:2072-2077.[Abstract/Free Full Text]
  4. 3
  5. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. CLSI document M100-S18. CLSI, Wayne, PA.
  6. 4
  7. Delmas, J., J. P. Chacornac, F. Robin, P. Giammarinaro, R. Talon, and R. Bonnet. 2008. Evaluation of the Vitek 2 system with a variety of Staphylococcus species. J. Clin. Microbiol. 46:311-313.[Abstract/Free Full Text]
  8. 5
  9. Fahr, A.-M., U. Eigner, M. Armbrust, A. Caganic, G. Dettori, C. Chezzi, L. Bertoncini, M. Benecchi, and M. G. Menozzi. 2003. Two-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp. J. Clin. Microbiol. 41:1135-1142.[Abstract/Free Full Text]
  10. 6
  11. Falcone, M., F. Campanile, M. Giannella, S. Borbone, S. Stefani, and M. Venditti. 2006. Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases. Diagn. Microbiol. Infect. Dis. 57:325-331.[Medline]
  12. 7
  13. Ghebremedhin, B., F. Layer, W. Konig, and B. Konig. 2008. Genetic classification and distinguishing of Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. J. Clin. Microbiol. 46:1019-1025.[Abstract/Free Full Text]
  14. 8
  15. Giammarinaro, P., S. Leroy, J.-P. Chacornac, J. Delmas, and R. Talon. 2005. Development of a new oligonucleotide array to identify staphylococcal strains at species level. J. Clin. Microbiol. 43:3673-3680.[Abstract/Free Full Text]
  16. 9
  17. Heikens, E., A. Fleer, A. Paauw, A. Florijn, and A. C. Fluit. 2005. Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative staphylococci. J. Clin. Microbiol. 43:2286-2290.[Abstract/Free Full Text]
  18. 10
  19. Huang, Y.-C., Y.-H. Wang, L.-H. Su, Y.-H. Chou, R.-I. Lien, and T.-Y. Lin. 2006. Determining the significance of coagulase-negative staphylococci identified in cultures of paired blood specimens from neonates by species identification and strain clonality. Infect. Control Hosp. Epidemiol. 27:70-73.[CrossRef][Medline]
  20. 11
  21. Huebner, M. D. J., and M. D. D. A. Goldmann. 1999. Coagulase-negative staphylococci: role as pathogens. Annu. Rev. Med. 50:223-236.[CrossRef][Medline]
  22. 12
  23. Kloos, W. E., C. G. George, J. S. Olgiate, L. Van Pelt, M. L. McKinnon, B. L. Zimmer, E. Muller, M. P. Weinstein, and S. Mirrett. 1998. Staphylococcus hominis subsp. novobiosepticus, a novel trehalose- and N-acetyl-D-glucosamine-negative, novobiocin- and multiple-antibiotic-resistant subspecies isolated from human blood cultures. Int. J. Syst. Bacteriol. 48:799-812.[Abstract/Free Full Text]
  24. 13
  25. Kwok, A. Y. C., and A. W. Chow. 2003. Phylogenetic study of Staphylococcus and Macrococcus species based on partial hsp60 gene sequences. Int. J. Syst. Evol. Microbiol. 53:87-92.[Abstract/Free Full Text]
  26. 14
  27. Layer, F., B. Ghebremedhin, K. A. Moder, W. Konig, and B. Konig. 2006. Comparative study using various methods for identification of Staphylococcus species in clinical specimens. J. Clin. Microbiol. 44:2824-2830.[Abstract/Free Full Text]
  28. 15
  29. Takahashi, T., I. Satoh, and N. Kikuchi. 1999. Phylogenetic relationships of 38 taxa of the genus Staphylococcus based on 16S rRNA gene sequence analysis. Int. J. Syst. Bacteriol. 49:725-728.[Abstract/Free Full Text]
  30. 16
  31. Viale, G., and S. Stefani. 2006. Vascular catheter-associated infections: a microbiological and therapeutic update. J. Chemother. 18:235-249.[Medline]
  32. 17
  33. von Eiff, C., G. Peters, and C. Heilmann. 2002. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect. Dis. 2:677-685.[CrossRef][Medline]


Journal of Clinical Microbiology, November 2008, p. 3826-3828, Vol. 46, No. 11
0095-1137/08/$08.00+0     doi:10.1128/JCM.00877-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brigante, G.
Right arrow Articles by Stefani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brigante, G.
Right arrow Articles by Stefani, S.